Orphenadrine Citrate
Indications
Registered South African indications:
- Conditions involving skeletal muscle spasm
- Such as low back pain and torticollis and also those resulting from trauma such as whiplash injury
Cautions
Contraindications
South African recommendations
- Pregnancy
- Glaucoma
- Tachycardia
- Urinary retention
- Achalasia
- Prostatic hypertrophy
- Bladder neck obstruction
- Myasthenia gravis
- Peptic ulcer stenosing
- Pyloric or duodenal obstruction
- Porphyria
Cautions
- Breastfeeding
- Hepatic impairment
- Renal impairment
- Elderly (particularly males)
- Micturition difficulties
- Cardiac insufficiency
- Tachycardia
- Heart failure
- Thyrotoxicosis
- Abrupt discontinuation
Adult dosage
Forms avail. in SA and covered in this monograph: tab
Dosages below include:
- South African registered indications and dosages
South African registered indications and dosages
Conditions involving skeletal muscle spasm
- Such as low back pain and torticollis and also those resulting from trauma such as whiplash injury
- Oral (tab): 100mg, 8-12hrly with water
Paediatric dosage
No information available for children in South Africa
Special populations
Pregnancy
- Contraindicated
- Safe use of orphenadrine has not been established with respect to adverse effects on foetal development
- Orphenadrine citrate should therefore be used in women of childbearing potential and particularly during early pregnancy only when in the judgment of the physician the potential benefits outweigh the possible hazards
Breastfeeding
- Caution; no information available
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Central Nervous System Disorders
- Dizziness
- Sedation
- Confusion
- Nervousness
- Hallucinations
- Convulsions
- Insomnia
- Euphoria
- Memory disturbances
- Co-ordination disturbances
- Restlessness
Cardiovascular Disorders
- Tachycardia
Gastrointestinal Disorders
- Dry mouth
- Gastrointestinal disturbances
- Nausea
- Constipation
Genitourinary Disorders
- Urinary retention
Immune System Disorder
- Hypersensitivity reaction
Sensory Disorders
- Accommodation disorders
Interactions
- Antimuscarinic agents
Monitoring
None routine
Mechanism of action
Orphenadrine citrate is a centrally acting anticholinergic. It relaxes skeletal muscle spasms without affecting normal muscle tone.
Dosage forms
- Tablet
Formulation
Tablet 100mg
- Norflex (iNova Pharma) originator
References
1. SAMF_pg411+466 2. PI: Norflex Tablets 100mg, iNova Pharmaceuticals (Pty)Ltd:Date of registration 21 Feb 1985 [https://drive.google.com/drive/u/0/folders/1eci9ghy0nRSxfat6mOr-3TtneqLfADQo] 3. PI: Disipal tablets 50mg, iNova Pharmaceuticals (Pty)Ltd:Date of registration 24 Jul 1979 [https://drive.google.com/drive/u/0/folders/1eci9ghy0nRSxfat6mOr-3TtneqLfADQo] 4. PI: Phenerine tablets 50mg, Pharmacare (Pty)Ltd:Date of registration Aug 1978 [https://drive.google.com/drive/u/0/folders/1eci9ghy0nRSxfat6mOr-3TtneqLfADQo] 5. Drugs.com: Orphenadrine; Downloaded online 26 Nov 2018 [https://drive.google.com/drive/u/0/folders/1eci9ghy0nRSxfat6mOr-3TtneqLfADQo] 6. U2D: Orphenadrine: Drug Information; Uptodate; Downloaded online 16 Aug 2018 [https://drive.google.com/drive/u/0/folders/1eci9ghy0nRSxfat6mOr-3TtneqLfADQo] [https://www.uptodate.com/contents/orphenadrine-drug-information?search=orphenadrine&source=panel_search_result&selectedTitle=1~7&usage_type=panel&kp_tab=drug_general&display_rank=1#F50991304] 7. https://www.medicines.org.uk/emc/medicine/2256 18 September 2012_Astellas_disipal 50mg 8. EMG-Clinical Pharmacologist - Guidelines Review 9. NAPOS The Drug Database for Acute Porphyria: M03BC01 Orphenadrine; Accessed online 04 Sep 2018 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=M03BC01&l=gbr] 10. South African Institute for Drug-Free Sport: Norflex Tablets; Accessed online 04 Sep 2018 [http://www.drugfreesport.org.za/online-medication-check/] 11. SmPC: Orphenadrine Hydrochloride 50mg/5ml Oral Solution, Rosemont Pharmaceuticals Limited: Last updated on eMC: 06 Aug 2013; Downloaded online 11 Dec 2018 [https://www.medicines.org.uk/emc/product/6691] 12. PI: Norflex 100mg Tablets, iNova Pharmaceuticals; Date of revision: 19 Sept 2021; Downloaded: 23 Mar 2023 [https://medsinfoportal.sahpra.org.za/pi/83bd0e36d92bef41fc3af9294c55c6fa.pdf] No SmPC for Orphenadrine citrate checked 29 March 2023
Brands & products
3 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days oldtabletGeneric· 3 products
from R2.90/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Uniflex (was Besenol nc) | 35 mg | 50 | S2 | R144.86 | R2.90 | R62.00 | 881767026 |
| Norflex | 100 mg | 50 | S2 | R180.31 | R3.61 | R74.27 | 747521018 |
| Norflex | 100 mg | 20 | S2 | R83.00 | R4.15 | R40.60 | 747521019 |
- Norflex
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.